Anastrozole (Page 8 of 8)

Package/Label Display Panel

NDC 0093-7536-56

Anastrozole Tablets, USP

1 mg

PHARMACIST: Please dispense with attached Patient Information leaflet

Rx only

30 TABLETS

Rev. D 12/2020
(click image for full-size original)
ANASTROZOLE
anastrozole tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-7536
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ANASTROZOLE (ANASTROZOLE) ANASTROZOLE 1 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSE 2910 (5 MPA.S)
LACTOSE MONOHYDRATE
POLYETHYLENE GLYCOL 400
POLYETHYLENE GLYCOL 6000
MAGNESIUM STEARATE
POVIDONE K30
SODIUM STARCH GLYCOLATE TYPE A POTATO
TITANIUM DIOXIDE
Product Characteristics
Color white (white to off-white) Score no score
Shape ROUND Size 6mm
Flavor Imprint Code TEVA;A10
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-7536-56 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078058 06/28/2010
Labeler — Teva Pharmaceuticals USA, Inc. (001627975)

Revised: 12/2020 Teva Pharmaceuticals USA, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.